Matches in DBpedia 2016-04 for { ?s ?p "Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Budipine abstract "Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.".
- Q28128 abstract "Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.".
- Budipine comment "Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.".
- Q28128 comment "Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.".